Citations

Showing 10 of 108081 citations.

Retrospective Evaluation of the Association of Oxacillin MIC on Acute Treatment Outcomes with Cefazolin and Antistaphylococcal Penicillins in Methicillin-Susceptible Staphylococcus aureus Bacteremia
Hess, Kyle A., Kooda, Kirstin , Shulha, Jennifer A., Mara, Kristin C. , Mara, Kristin, Go, John R, Mara, Kristin C , Shulha, Jenny , Go, John Raymond , Fida, Madiha , DeSimone, Daniel C. , Stevens, Ryan W.

Mayo Clinic

Journal of Clinical Microbiology | March 29, 2023 | Volume: 61 | Issue: 4 | Pages: No page available

10.1128/jcm.00039-23 | PMID 36988505 Get It

Antistaphylococcal penicillins (ASP) and cefazolin are first-line treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. Borderline oxacillin resistance (i.e., oxacillin MICs 1-8 μg/mL) is observed in strains hyperproducing beta-lactamases.
A pilot evaluation of social needs among gynecologic oncology patients in inpatient versus outpatient settings
Nora, Anne, Hartman, Caroline, Summers, Karen M. , Syrop, Craig H., Haugsdal, Michael L , Greenwood, Anna

Mayo Clinic

Proceedings in Obstetrics and Gynecology | March 29, 2023 | Volume: 12 | Issue: 1 | Pages: No page available

10.17077/2154-4751.31886 Get It

The WHO defines social determinants of health (SDoH) as the conditions in which we are born, grow, work, and live as well as other large systems that positively or negatively affect our health. Many healthcare systems currently lack the resources and strategies required to accurately assess and address SDoH. Action must be taken because studies have found that chronic diseases, including cancer, are affected by SDoH. The aim of this study is to identify the incidence of social needs in an inpatient gynecologic oncology population and its relation to patient demographics and clinical diagnostic data to guide and inform future intervention. Patients agreeing to participate in the study completed a needs assessment survey during their inpatient stay at the hospital between November 2020 to March 2021. The survey contained seven questions, six of which were questions screening for social needs including food and housing security, transportation means, financial stability, health literacy, and social support. Responses were considered positive if any degree of need was reported. Demographic and cancer diagnosis data were then collected and included zip code, race, cancer stage and age at diagnosis, treatment history, and number of hospital admissions and length of stay over the past 12 months. The most substantial reported needs across all gynecologic malignancies were social support (65%), health literacy (37%), and financial need (22%). Less need was reported in the categories of food (11%), housing (7%), and transportation (4%). SDoH have been studied in the outpatient gynecologic population and the needs seen in this study are similar to the needs of that population. However, there are likely different challenges and frequencies of unmet need in the different types of gynecologic cancers that may affect the stage at which their cancer is diagnosed as well as the number of hospital admissions related to their cancer care.
Fostering diagnostics of cardiovascular disease in diabetics using ABI and baPWV – correspondence
Manan, Sadia , Shaikh, Omer Ahmed , Shaikh, Omer Ahmed , Saleem, Kanza, Ullah, Irfan , Asghar, Muhammad Sohaib , Ullah, Irfan , Asghar, Muhammad S , Saleem, Kanza

Mayo Clinic

Annals of Medicine & Surgery | March 29, 2023 | Volume: 85 | Issue: 4 | Pages: 1316-1316

10.1097/ms9.0000000000000370 | PMID 37113832 Get It

Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
Shaikh, Omer Ahmed , Shaikh, Omer Ahmed , Aftab, Rameel Muhammad, Baktashi, Haisum, Ullah, Irfan , Asghar, Muhammad Sohaib , Ullah, Irfan , Asghar, Muhammad S

Mayo Clinic

Annals of Medicine & Surgery | March 29, 2023 | Volume: 85 | Issue: 4 | Pages: 1312-1313

10.1097/ms9.0000000000000338 | PMID 37113818 Get It

Irritable Bowel Syndrome (IBS) is a chronic, one of the commonest and persistent gastrointestinal (GI) disorder. Previously, the management plan for IBS-D included enhancing awareness; first line treatment included an increased dietary fiber intake, opioids for diarrhea and antispasmodics for pain management. A recent treatment guideline by the American Gastroenterology Association (AGA) suggests a modified approach to treating patients with IBS-D. Eight drug recommendations were made, and a set of instructions on when to employ which medication was devised. With the incorporation of these structured guidelines, a more tailored and focused approach to IBS management may become plausible.
Causes, Diagnostic Testing, and Treatment of Residual Symptoms in Patients With IBD With Quiescent Disease
Dunleavy, Katie A. , Cross, Raymond, Raffals, Laura E., Cross, Raymond K. , Dunleavy, Katie , Raffals, Laura E.

Mayo Clinic

American Journal of Gastroenterology | March 29, 2023 | Volume: 118 | Issue: 11 | Pages: 1909-1914

10.14309/ajg.0000000000002267 | PMID 36988311 Get It

Ketamine for Treatment‐Resistant bipolar depression—A reality check!
Singh, Balwinder , Singh, Balwinder

Mayo Clinic

Bipolar Disorders | March 29, 2023 | Volume: 25 | Issue: 3 | Pages: 247-248

10.1111/bdi.13324 | PMID 36978284 Get It

Fraction of Osteocalcin Endothelial Progenitor Cells and Cardiovascular Risk
Ӧzcan, Ilke , Kanaji, Yoshihisa , Rajotia, Arush , Toya, Takumi , Akhiyat, Nadia , Morse, David , Lerman, Lilach O. , Lerman, Amir , Ozcan, Ilke , Lerman, Amir , Toya, Takumi , Morse, David , Kanaji, Yoshihisa

Mayo Clinic

Circulation Research | March 29, 2023 | Volume: 132 | Issue: 9 | Pages: 1162-1164

10.1161/circresaha.122.322407 | PMID 36987925 Get It

Under (back) pressure: Better collateral flow may facilitate clot removal in ischemic stroke: A systematic review and meta-analysis
Seymour, Trey , Kobeissi, Hassan , Ghozy, Sherief , Kadirvel, Ramanathan , Kallmes, David F. , Kadirvel, Ram , Kallmes, David F , Ghozy, Sherief , Seymour, Trey J , Kobeissi, Hassan , Gupta, Rishabh

Mayo Clinic

Interventional Neuroradiology | March 29, 2023 | Volume: 32 | Issue: 3 | Pages: 706-712

10.1177/15910199231166739 | PMID 36987690 Get It

Background Collateral status may facilitate clot removal and affect rates of successful reperfusion following endovascular therapy (EVT) for acute ischemic stroke (AIS). Methods Following the PRISMA guidelines, a systematic literature review of the English language literature was conducted using PubMed, Scopus, Web of Science, and Embase. Papers which focused on collateral status and patients treated with EVT for AIS were included in our analysis. Outcomes of interest included collateral score grading, rates of successful reperfusion defined as thrombolysis in cerebral infarction (TICI) score 2b-3 and onset to revascularization time. We calculated pooled odds ratio (OR) or mean difference (MD) and their corresponding 95% confidence intervals (CI) based on collateral status. Results 16 studies, with 6073 patients, were included in our analysis. Among the included studies, there were six different collateral grading scales, which were dichotomized into “good to moderate” and “poor” collaterals. Odds of successful reperfusion were significantly higher among patients with good to moderate collateral circulation compared to those with poor collaterals (OR = 1.61; 95% CI = 1.24 to 2.09; P -value < 0.001); however, there was heterogeneity among included studies (I2 = 5 4%; P -value = 0.008). Onset to revascularization time was comparable between patients with good to moderate collateral circulation compared to those with poor collaterals (MD = 3.91 min; 95% CI = −8.71 to 16.53; P -value = 0.544); however, there was heterogeneity among included studies (I2= 60%; P -value = 0.014). Conclusions The presence of good collaterals may increase the odds of achieving successful reperfusion following EVT for AIS. Improved collateral flow was associated with improved angiographic outcomes, although future work is needed to determine if a causal relationship exists.
Clinical Course of Patients with Hypertrophic Cardiomyopathy Away from Tertiary Referral Care
Garmany, Ramin , Bos, J. Martijn , Ommen, Steve R. , Ackerman, Michael J. , Geske, Jeffrey B. , Bos, Johan M , Geske, Jeffrey B , Garmany, Ramin

Mayo Clinic

ESC Heart Failure | March 29, 2023 | Volume: 10 | Issue: 3 | Pages: 1919-1927

10.1002/ehf2.14345 | PMID 36987533 Get It

Abstract Aims Data on the clinical course of hypertrophic cardiomyopathy (HCM) are mainly derived from tertiary HCM centre studies, and knowledge of clinical outcomes of patients leaving specialty care and returning to local physicians is limited due to gaps between clinical encounters or complete loss of follow-up. This survey aims to describe the clinical course of HCM in patients following their evaluation at a tertiary referral centre. Methods and results A comprehensive outcomes survey was developed and sent to 4495 eligible patients with HCM previously evaluated at Mayo Clinic. Questions assessed general well-being, New York Heart Association class, procedures performed, and probable HCM-triggered ventricular arrhythmic events (VAEs) since last visit. In total, 2058 patients (mean age 63 ± 15 years; 42% female) responded to the survey covering a total of 10 510 patient-years with an average of 5.4 ± 6.4 years of follow-up since their last on-campus/virtual visit to Mayo Clinic. During their time away from specialty care, 20% of patients reported having cardiac-related hospitalizations and 25% reported having cardiac-related procedures. Similar to high-risk referral cohorts, 5% of patients reported VAEs with an event rate of 0.98 events/100 patient-years. The prevalence of atrial fibrillation, syncope, pre-syncope, cardiac-related hospitalizations, and VAEs during time away from specialty care increased significantly with increasing New York Heart Association class (P &lt; 0.001). Conclusions Acknowledging ascertainment bias, the clinical course of patients away from tertiary care may be more severe than previously anticipated. Among those with exertional symptoms, HCM-related morbidity increased substantially. Higher risk HCM patients should remain in contact with HCM specialty care.
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
Heater, Natalie Knox , Okuno, Scott H. , Attia, Steven , Seetharam, ­Mahesh , Yoon, Janet, Chawla, Sant P. , Milhem, Mohammed , Monga, Varun , Skubitz, Keith M. , Charlson, John A. , Hirbe, Angela C. , Weiss, Mia C. , Tine, Brian A. Van , Agulnik, Mark , Robinson, Steven, Monga, Varun , Skubitz, Keith , Hirbe, Angela C , Van Tine, Brian A , Agulnik, Mark , Milhem, Mohammed M , Robinson, Steven I. , Siontis, Brittany L.

Mayo Clinic

Journal of Clinical Medicine | March 29, 2023 | Volume: 12 | Issue: 7 | Pages: 2561

10.3390/jcm12072561 | PMID 37048645 Get It

The treatment of sarcoma necessitates a collaborative approach, given its rarity and complex management. At a single institution, multidisciplinary teams of specialists determine and execute treatment plans involving surgical, radiation, and medical management. Treatment guidelines for systemic therapies in advanced or nonresectable soft tissue sarcoma have advanced in recent years as new immunotherapies and targeted therapies become available. Collaboration between institutions is necessary to facilitate accrual to clinical trials. Here, we describe the success of the Midwest Sarcoma Trials Partnership (MWSTP) in creating a network encompassing large academic centers and local community sites. We propose a new model utilizing online platforms to expand the reach of clinical expertise for the treatment of advanced soft tissue sarcoma.